15 new drugs added to Medicare price negotiations - Takeaways - MDSpire

15 new drugs added to Medicare price negotiations

  • By

  • John Wilkerson

  • January 27, 2026

  • 0 min

Share

  • 1

    The Trump administration announced 15 additional drugs for Medicare price negotiation, including physician-administered treatments.

  • 2

    This marks the first year that Part B drugs, typically administered in doctor offices, are eligible for price negotiation.

  • 3

    Negotiated prices for these drugs will take effect in 2028, aiming to reduce costs for patients.

  • 4

    Some cancer and HIV drugs may see significant savings due to their protected-class status in Medicare.

  • 5

    The addition of physician-administered drugs complicates the negotiation process due to varying data availability.

Original Source(s)

15 new drugs added to Medicare price negotiations

  • by John Wilkerson

  • January 27, 2026

Related Content

Mammography Results and BI-RADS Agreement Among Women Participating in a Community Health Initiative in Uganda

Analyzing the Joint Impact of Seven Air Pollutants on Breast Cancer Risk: Findings from a Case-Control Study within the French E3N-Generations Cohort

Future landscapes of women’s hormone-sensitive cancers: unraveling global trends, age stratification, and regional inequities (1990–2035)